Industry NewsNovel Test Can Identify Patients in Intensive Care at Greatest Risk of Life-Threatening Infections
Industry NewsNovel Drug for Mild-to-Moderate Alzheimer's Disease Demonstrates Safety and Tolerability at 18-Months